Cargando…
FBXO45 is a potential therapeutic target for cancer therapy
FBXO protein 45 (FBXO45), a substrate-recognition subunit of E3 ligases, has been characterised to have pivotal roles in many human diseases, including nervous system diseases, inflammatory diseases and human malignancies. In this article, we describe the expression of FBXO45 in several types of hum...
Autores principales: | Lin, Min, Wang, Zhi-wei, Zhu, Xueqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335190/ https://www.ncbi.nlm.nih.gov/pubmed/32655893 http://dx.doi.org/10.1038/s41420-020-0291-2 |
Ejemplares similares
-
Fbxo22 promotes cervical cancer progression via targeting p57(Kip2) for ubiquitination and degradation
por: Lin, Min, et al.
Publicado: (2022) -
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation
por: Wu, Linhui, et al.
Publicado: (2022) -
HDL as a Biomarker, Potential Therapeutic Target, and Therapy
por: Navab, Mohamad, et al.
Publicado: (2009) -
miR-124, a potential therapeutic target in colorectal cancer
por: Qin, Zhen, et al.
Publicado: (2019) -
LIM kinases in synaptic plasticity and their potential as therapeutic targets
por: Halász, Éva, et al.
Publicado: (2020)